FMS and FME Related Headlines
Go Back- Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
- Fresenius Medical Care starts EUR 600 million share buyback program
- Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
- Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
- Fresenius Medical Care announces €1 billion share buyback program
- Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
- Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
- Fresenius Medical Care reappoints CFO Martin Fischer for five years
- Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
- Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
- Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
- Fresenius Medical Care accelerates share buyback with €415 million tranche
- Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
- Fresenius Medical Care names Charles Hugh-Jones as global chief medical officer
- Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
- Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
- Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
- Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
- Fresenius Medical Care invests €312 million in Interwell Health unit
- Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
- Fresenius Medical Care launches EUR 600 million share buyback program
- Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
- Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
- Frenova partners with GENEWIZ for kidney disease genomics research
- Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
- Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
- Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation
- Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with
FMS and FME Related Press Releases
Go Back- Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
- Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
- Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
- Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
- Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
- Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
- Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
- Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
- Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
- Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
- Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
- Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
- Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
- Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
- Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
- Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
- Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
- Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
- Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation
- Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with
FMS and FME Related SEC Filings
Go Back- Form 6-K Fresenius Medical Care For: May 28
- Form SD Fresenius Medical Care
- Form 6-K Fresenius Medical Care For: May 26
- Form 6-K Fresenius Medical Care For: Mar 31
- Form 6-K Fresenius Medical Care For: May 05
- Form 6-K Fresenius Medical Care For: Apr 14
- Form 3 Fresenius Medical Care For: Mar 18 Filed by: Renkewitsch Olga
- Form 6-K Fresenius Medical Care For: Feb 24
- Form IRANNOTICE Fresenius Medical Care
- Form 20-F Fresenius Medical Care For: Dec 31
- Form 6-K Fresenius Medical Care For: Feb 24
- Form 6-K Fresenius Medical Care For: Jan 12
- Form 6-K Fresenius Medical Care For: Dec 10
- Form 6-K Fresenius Medical Care For: Nov 17
- Form 6-K Fresenius Medical Care For: Nov 04
- Form 6-K Fresenius Medical Care For: Sep 30
- Form 6-K Fresenius Medical Care For: Oct 01
- Form 6-K Fresenius Medical Care For: Sep 19
- Form 6-K Fresenius Medical Care For: Aug 11
- Form 6-K Fresenius Medical Care For: Jun 30
- Form 6-K Fresenius Medical Care For: Aug 05
- Form 11-K Fresenius Medical Care For: Dec 31
- Form 6-K Fresenius Medical Care For: Jun 17
- Form 6-K Fresenius Medical Care For: Jun 05
